Bluescope Steel share price climbs higher after avoiding criminal charges

BlueScope Steel Ltd (ASX: BSL) has been boosted by news that the ACCC will not pursue criminal cartel charges against the company.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The BlueScope Steel Limited (ASX: BSL) share price has climbed in early trade after the Australian Competition & Consumer Commission (ACCC) declined to press criminal cartel charges against the company.

What is happening with the ACCC?

On 30 August, BlueScope announced that the ACCC had commenced civil proceedings against the company and former employee Mr. Jason Ellis.

The Aussie regulator alleged that Mr Ellis attempted to induce Australian steel distributors and overseas manufacturers to engage in price-fixing through contract provisions.

Prior to the market open, BlueScope announced that the ACCC will not be pursuing criminal cartel proceedings against either the company or Mr. Ellis in relation to the same alleged dealings.

According to the release, the civil proceedings remain ongoing while the Commonwealth Director of Public Prosecutions (CDPP) has laid criminal obstruction charges against Mr. Ellis.

Has this affected the BlueScope share price?

Since the 30 August announcement, the BlueScope share price has fallen 6.65% lower to $11.66, prior to this morning's open. 

However, the BlueScope share price remains up 7.47% since the start of the year and BlueScope still boasts a market cap of just under $6 billion.

With criminal cartel proceedings being a weight off the company's shoulders, I'd expect to see the BlueScope share price climb higher as investors' confidence is boosted by this morning's announcement. 

Should you buy BlueScope shares?

Despite being up for the year, the BlueScope share price has still significantly underperformed the S&P/ASX 200 Index (INDEXASX: XJO) so far this year.

BlueScope shares are currently yielding 0.84% per annum, which isn't enough to entice me to buy them as an ASX dividend stock just at the minute.

I'd personally like to see some sustained capital gains over a period of 6–12 months to really consider adding a stock like BlueScope to my portfolio.

If I were going to gain exposure to a cyclical industry, given the state of the Aussie construction industry, I think I'd prefer to look at a large-cap mining stock such as BHP Group Ltd (ASX: BHP).

While the BHP share price has been hurt by the ongoing US–China trade war tensions, I think the fundamentals remain strong while a 5.41% dividend yield certainly sweetens the deal.

Motley Fool contributor Kenneth Hall has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

Fancy font saying top ten surrounded by gold leaf set against a dark background of glittering stars.
Share Gainers

Here are the top 10 ASX 200 shares today

Let's also take a look at what the various ASX sectors were doing this Wednesday.

Read more »

A young women pumps her fists in excitement after seeing some good news on her laptop.
Share Gainers

Why Argosy Minerals, Immutep, Pointsbet, and Regis Resources shares are racing higher

These shares are having a strong session on Wednesday. But why?

Read more »

Businessman smiles with arms outstretched after receiving good news.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another strong showing from the share market today.

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Healthco Healthcare, Medadvisor, Ramsay Health Care, and Tamboran shares are rising

These shares are having a strong session. But why?

Read more »

drug capsule opening up to reveal dollar signs signifying rising asx share price
Share Gainers

If you invested $6,000 in Mesoblast shares a month ago you'd have $15,636 now!

Mesoblast shares have been on a tear this past month. But why?

Read more »

Smiling man working on his laptop.
Share Gainers

Here are the top 10 ASX 200 shares today

It was back to the races for ASX shares today, in a confident start to the week.

Read more »

rising gold share price represented by a green arrow on piles of gold block
Share Gainers

Here are the top 10 ASX 200 shares today

It was a horrible way to end the trading week today for ASX investors.

Read more »

Female miner smiling at a mine site.
Share Gainers

Up 834% in a year, guess which ASX mining stock is hitting new all-time highs today

The ASX mining stock has gone from strength to strength over the past year.

Read more »